Heron Therapeutics, Inc. (HRTX)
0.40
-0.05
(-11.82%)
USD |
NASDAQ |
Jun 09, 16:00
0.40
0.00 (0.00%)
After-Hours: 18:30
Heron Therapeutics SG&A Expense (Quarterly) : 26.45M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 27.87M |
| Ironwood Pharmaceuticals, Inc. | 12.03M |
| ARS Pharmaceuticals, Inc. | 72.20M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |